Riesgos de Sangrado en Paracentesis

Incidencia y Tipos de Complicaciones Hemorrágicas

• La paracentesis es un procedimiento generalmente seguro con un riesgo de sangrado severo muy bajo (0,2-2,2% de las punciones), siendo la mortalidad extremadamente rara (0,02% de los procedimientos) 1, 2
• Las complicaciones hemorrágicas leves, como hematomas de la pared abdominal, ocurren en aproximadamente el 1% de los pacientes, incluso cuando el 71% de ellos tienen un tiempo de protrombina anormal 3, 4
• Las complicaciones hemorrágicas graves (hemoperitoneo o entrada de la aguja en el intestino) son extremadamente raras, ocurriendo en aproximadamente 1 de cada 1000 paracentesis 3, 5

Factores de Riesgo para Sangrado

• La insuficiencia renal parece ser un factor de riesgo importante; en un estudio de 4729 paracentesis, ocho de nueve complicaciones hemorrágicas ocurrieron en pacientes con insuficiencia renal 3, 4
• No existe un punto de corte basado en evidencia para parámetros de coagulación más allá del cual se deba evitar la paracentesis 3, 5

Prevención del Sangrado

• El cuadrante inferior izquierdo es el sitio preferido para la paracentesis porque tiene una mayor profundidad de ascitis y una pared abdominal más delgada 3, 1
• La ubicación recomendada es 2 dedos (3 cm) por encima y 2 dedos medial a la espina ilíaca anterosuperior 3, 5
• Se debe evitar el área de las arterias epigástricas inferiores, que se encuentran a medio camino entre el pubis y las espinas ilíacas anterosuperiores 3, 5

Manejo de la Coagulopatía

• El uso rutinario profiláctico de plasma fresco congelado o plaquetas antes de la paracentesis no está recomendado 3, 4, 1
• La coagulopatía debe impedir la paracentesis solo cuando hay hiperfibrinólisis clínicamente evidente (equimosis/hematoma tridimensional) o coagulación intravascular diseminada clínicamente evidente 3, 4

Contraindicaciones

• Contraindicaciones absolutas: Hiperfibrinólisis clínicamente evidente 4, Coagulación intravascular diseminada clínicamente evidente 3, 4
• Contraindicaciones relativas (requieren precaución especial): Embarazo 2, Distensión intestinal severa 2, Historia de cirugía abdominal extensa 2, Disfunción hepática severa 2, Disfunción renal severa 1, 2

Paracentesis Guidelines

Pre-Procedural Recommendations

• The European Association for the Study of the Liver (EASL) does not recommend routine measurement of prothrombin time and platelet count before performing therapeutic or diagnostic paracentesis 6
• The EASL also does not recommend routine infusion of blood products before the procedure 6

Procedure Technique

• The use of ultrasound guidance reduces the risk of hemorrhagic complications 6
• The EASL recommends using ultrasound guidance when available to reduce the risk of adverse events 6
• The puncture site should be at least 8 cm from the midline and 5 cm above the symphysis to minimize the risk of injury to the inferior epigastric artery 7

Patient Management

• In patients with tense ascites (grade 3), large-volume paracentesis is the treatment of choice 7
• All ascitic fluid should be drained in a single session, as quickly as possible during 1-4 hours 6
• After large-volume paracentesis (>5L), volume expansion with albumin (8g/L of ascites extracted) is recommended to prevent post-paracentesis circulatory dysfunction 7

Safety and Risks

• The EASL guidelines indicate that the procedure has a very low risk of local complications, particularly bleeding, even in patients with INR >1.5 and platelet count <50,000/μl 7

Paracentesis Safety and INR Levels

Introduction to Paracentesis Guidelines

• The Journal of Thrombosis and Haemostasis guidelines state that INR does not predict bleeding risk in patients with cirrhosis or those undergoing procedures 8
• A recent systematic review found weak or no association between INR and bleeding in 78 out of 79 studies assessed for pre-procedural bleeding prediction 8

Understanding INR Limitations

• There is no high-quality evidence that plasma transfusions reduce bleeding when administered to nonbleeding patients with incidentally abnormal INRs 9, 8
• INR was designed and validated only to assess coagulation status in patients receiving vitamin K antagonist therapy, not as a general predictor of bleeding risk is not applicable due to lack of citation, however, The Journal of Thrombosis and Haemostasis guidelines provide context 8

Practical Approach to Paracentesis

• Proceed with paracentesis regardless of INR level unless the patient is actively bleeding from another site 8
• Avoid routine prophylactic plasma or platelet transfusion, as this practice lacks biological plausibility and exposes patients to volumetric and immunologic risks without proven benefit 9, 8

Common Pitfalls to Avoid

• Delaying or avoiding paracentesis based solely on elevated INR values represents overreliance on a test that was never validated for bleeding prediction in non-anticoagulated patients and can lead to undertreatment of patients who would benefit from the procedure 9, 8

Minimum Platelet Count for Ascitic Tapping

Evidence-Based Approach to Platelet Counts and Paracentesis

• Paracentesis can be safely performed without a specific minimum platelet count threshold, and routine prophylactic platelet transfusion is not recommended regardless of platelet count, as stated by the American Gastroenterological Association and the American Association for the Study of Liver Diseases 10, 11
• There is no data-supported cutoff of coagulation parameters beyond which paracentesis should be avoided, according to the American Association for the Study of Liver Diseases 11
• In a landmark study of 1,100 large-volume paracenteses, there were no hemorrhagic complications despite platelet counts as low as 19,000 cells/mm³ (54% had counts <50,000/mm³) and no prophylactic transfusions were given, as reported by the American Association for the Study of Liver Diseases 11

Guideline Recommendations on Platelet Transfusion

• The routine prophylactic use of fresh frozen plasma or platelets before paracentesis is not recommended (Class III recommendation), as stated by the American Association for the Study of Liver Diseases 11
• Most guidelines state that if thrombocytopenia is severe (<40,000/mm³), many clinicians would give pooled platelets to reduce bleeding risk, though this is based on clinical practice rather than evidence, according to the European Association for Gastroenterology and Endoscopy 10

Understanding the Safety Profile

• Bleeding complications from paracentesis are rare, occurring in approximately 1% of patients (mostly minor abdominal wall hematomas), as reported by the American Gastroenterological Association 10
• Serious complications such as hemoperitoneum or bowel perforation occur in less than 1 in 1,000 procedures, according to the American Gastroenterological Association 10

Technical Considerations to Minimize Bleeding

• Use ultrasound guidance when available to reduce hemorrhagic complications, as recommended by the American Association for the Study of Liver Diseases 11
• Avoid the area of inferior epigastric arteries (midway between pubis and anterior superior iliac spines), as advised by the American Association for the Study of Liver Diseases 11
• Avoid visible collateral vessels, as recommended by the American Association for the Study of Liver Diseases 11

Prophylactic Blood Product Use Before Paracentesis

Guideline Recommendations

• Routine prophylactic administration of fresh frozen plasma (FFP) or platelets before paracentesis is not recommended (Class III recommendation) regardless of INR or platelet count abnormalities. [12][13]

Safety and Bleeding Risk

• Paracentesis is a low‑risk procedure; major bleeding occurs in < 0.1 % of cases (fewer than 1 in 1,000) even in patients with severe coagulopathy. 12
• A large cohort of ≈ 1,100 large‑volume paracenteses reported zero hemorrhagic complications despite platelet counts as low as 19 × 10⁹/L and INR values up to 8.7, with no prophylactic transfusions given. 12

Coagulation Parameters and Transfusion Thresholds

• Platelet counts above ≈ 40 × 10⁹/L are generally considered safe for paracentesis; a count of 75 × 10⁹/L falls well above this threshold. 14
• An INR of ≈ 1.7 represents only a mild elevation and does not predict increased bleeding risk in cirrhosis. [15][13]

Ineffectiveness and Risks of Fresh Frozen Plasma

• Achieving any INR correction with FFP requires large volumes (10–15 mL/kg, ≈ 250 mL per unit), which can raise portal pressure and precipitate volume‑related complications. [15][16]13
• Potential adverse effects of FFP transfusion include transfusion‑related acute lung injury, volume overload, infectious transmission, development of HLA antibodies (impacting future transplantation), and exacerbation of portal hypertension. [15][16]

True Contraindications to Paracentesis

• Paracentesis should be avoided only in the presence of clinically evident hyperfibrinolysis (e.g., extensive ecchymosis or hematoma formation) or disseminated intravascular coagulation. 15

Interpretation of Coagulation Tests in Cirrhosis

• INR is not a reliable guide for transfusion decisions in cirrhosis because it was validated for warfarin monitoring, not for bleeding risk in liver disease; the re‑balanced hemostasis in cirrhosis means standard coagulation assays do not reflect actual bleeding propensity. [13][15]

Practical Management Recommendations

• Proceed directly with paracentesis without any blood‑product transfusion. [15][12]13
• Employ ultrasound guidance when available to further reduce complication rates. 12
• Use the left lower quadrant (approximately two finger‑breadths cephalad and medial to the anterior superior iliac spine) as the preferred puncture site. 12
• Avoid the inferior epigastric arteries and any visibly enlarged collateral vessels during needle insertion. 12

Post‑Procedure Albumin Replacement

• When more than 5 L of ascitic fluid is removed, administer albumin 8 g per liter removed to prevent post‑paracentesis circulatory dysfunction. [14][17]